Kansas Journal of Medicine最新文献

{"title":"Comprehension Profile of Patient Education Materials in Endocrine Care.","authors":"Som P Singh,&nbsp;Fahad M Qureshi,&nbsp;Kiera G Borthwick,&nbsp;Sagar Singh,&nbsp;Shreya Menon,&nbsp;Brandon Barthel","doi":"10.17161/kjm.vol15.16529","DOIUrl":"https://doi.org/10.17161/kjm.vol15.16529","url":null,"abstract":"<p><strong>Introduction: </strong>The internet is an ever-evolving resource to improve healthcare literacy among patients. The nature of the internet can make it difficult to condense educational materials in a manner applicable to a worldwide patient audience. Within the realm of endocrinology, there is lack of a comprehensive analysis regarding these pathologies in addition to education materials related to their medical work-up or management. The aim of this study was to assess contemporary online patient education material in endocrinology and management of care.</p><p><strong>Methods: </strong>Analysis of the readability of 1,500 unique online education materials was performed utilizing seven readability measures: Flesch Reading Ease (FRE), Flesch-Kincaid Grade Level (FKGL), Gunning Fog Index Readability Formula (FOG), Simple Measure of Gobbledygook Index (SMOG), Coleman-Liau Index (CLI), automated readability index (ARI), and Linsear Write Formula (LWF).</p><p><strong>Results: </strong>The average grade level readability scores from six measures (e.g., FKGL, FOG, SMOG, CLI, ARI, LWF) was more than or equal to 11 which corresponds to a reading level at or above the 11th grade. The average FRE between adrenal, diabetes, and thyroid-related education m aterial ranged between \"fairly difficult\" to \"very difficult\".</p><p><strong>Conclusions: </strong>The readability of contemporary online endocrine education material did not meet current readability recommendations for appropriate comprehension of the general audience.</p>","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"247-252"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5f/cd/15-247.PMC9311631.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Scleroderma as an Uncommon Cause of Pericardial Effusion.","authors":"Brianna L Yee,&nbsp;Neilmegh L Varada,&nbsp;Osman M Rahimi,&nbsp;Chriselyn F Palma,&nbsp;Omar S Al-Taweel,&nbsp;Chowdhury H Ahsan","doi":"10.17161/kjm.vol15.17026","DOIUrl":"https://doi.org/10.17161/kjm.vol15.17026","url":null,"abstract":"257 Scleroderma as an Uncommon Cause of Pericardial Effusion Brianna L. Yee, M.D., Neilmegh L. Varada, D.O., Osman M. Rahimi, D.O., Chriselyn F. Palma, D.O., Omar S. Al-Taweel, M.D., Chowdhury H. Ahsan, M.D. University of Nevada-Las Vegas, Kirk Kerkorian School of Medicine, Las Vegas, NV Received March 21, 2022; Accepted for publication May 16, 2022; Published online July 21, 2022 https://doi.org/10.17161/kjm.vol15.17026","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"257-258"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/27/15-257.PMC9311772.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bilateral Upper Lobe Collapse Secondary to Vaping.","authors":"Nicholas Tuck,&nbsp;Karen Gichohi,&nbsp;Thomas Moore","doi":"10.17161/kjm.vol15.17003","DOIUrl":"https://doi.org/10.17161/kjm.vol15.17003","url":null,"abstract":"253 Bilateral Upper Lobe Collapse Secondary to Vaping Nicholas Tuck, M.D.1, Karen Gichohi, M.D.1, Thomas Moore, M.D., FACP, FIDSA1,2 1University of Kansas School of Medicine-Wichita, Wichita, KS Department of Internal Medicine 2Infectious Disease Consultants, Wichita, KS Received March 12, 2022; Accepted for publication April 25, 2022; Published online July 21, 2022 https://doi.org/10.17161/kjm.vol15.17003","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"253-254"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/25/d7/15-253.PMC9311635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40639948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient Controlled Analgesia and an Alternative Protocol: A Comparison of Outcomes After Thoracic and Lumbar Surgery.","authors":"Will Donelson,&nbsp;Joey Dean,&nbsp;Elizabeth Ablah,&nbsp;Clara Whitaker,&nbsp;Gina M Berg,&nbsp;Kyle McCormick,&nbsp;Hayrettin Okut,&nbsp;Camden Whitaker","doi":"10.17161/kjm.vol15.15972","DOIUrl":"https://doi.org/10.17161/kjm.vol15.15972","url":null,"abstract":"<p><strong>Introduction: </strong>Patient controlled analgesia (PCA) is a common form of pain management after spine surgeries, in which patients get custom control of their opioid dose. PCA has been demonstrated as a safe form of analgesia; however, use of PCA comes with risks that can be mitigated by opting for alternative pain management. This study aimed to compare the outcomes of patients using PCA to those with an alternative analgesia protocol that does not involve PCA.</p><p><strong>Methods: </strong>A retrospective chart review from January 2017 to July 2018 was conducted. Patients included in this study were those 18 or older who were admitted to a large midwestern tertiary medical center in Wichita, Kansas, and underwent thoracic or lumbar spinal surgery from a single spine surgeon. Data from patient demographics, comorbidities, and type of procedure were collected and compared to control for possible confounding variables. Patients were divided into two groups: patients receiving a PCA pain protocol post-operatively and those receiving a non-PCA protocol. Statistical analyses were performed and all tests with p < 0.05 were considered significant.</p><p><strong>Results: </strong>This study found patients in the PCA protocol had similar outcomes to those in the alternative analgesia protocol. This was true for both primary and secondary outcomes. The primary outcome was patient length of stay after the operation. Secondary outcomes included readmission rates, frequency of naloxone rescue, transfers to higher levels of care, and total opioid consumption.</p><p><strong>Conclusions: </strong>This study supported that a non-PCA protocol for post-operative pain management yields similar outcomes to a PCA protocol in the setting of thoracic and lumbar surgery.</p>","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"237-240"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/02/08/15-237.PMC9311771.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis.","authors":"Umar Hayat,&nbsp;Muhammad Zubair Ashfaq,&nbsp;Luke Johnson,&nbsp;Ryan Ford,&nbsp;Chelsea Wuthnow,&nbsp;Kevin Kadado,&nbsp;Katia El Jurdi,&nbsp;Hayrettin Okut,&nbsp;William Ransom Kilgore,&nbsp;Maha Assi,&nbsp;Ali A Siddiqui","doi":"10.17161/kjm.vol15.16522","DOIUrl":"https://doi.org/10.17161/kjm.vol15.16522","url":null,"abstract":"<p><strong>Introduction: </strong>Metabolic-associated fatty liver disease (MAFLD) is a hepatic manifestation of metabolic syndrome (MS). MAFLD patients have a higher prevalence of COVID-19. MAFLD also is associated with worse clinical outcomes of COVID-19, such as disease severity, intensive care unit (ICU) admission rate, and higher mortality rates. However, this evidence has not been well characterized in the literature. This meta-analysis aimed to determine the clinical outcomes of COVID-19 among MAFLD patients compared to the non-MAFLD group.</p><p><strong>Methods: </strong>A comprehensive search was conducted in the Cumulative Index of Nursing and Allied Health (CINAHL), PubMed/Medline, and Embase for studies reporting MAFLD prevalence among COVID-19 patients and comparing clinical outcomes such as severity, ICU admission, and mortality among patients with and without MAFLD. The pooled prevalence of MAFLD among COVID-19 patients and the pooled odds ratios (OR) with 95% confidence intervals (CI) for clinical outcomes of COVID-19 were calculated.</p><p><strong>Results: </strong>Sixteen observational studies met inclusion criteria involving a total of 11,484 overall study participants, including 1,746 MAFLD patients. The prevalence of COVID-19 among MAFLD patients was 0.29 (95% CI: 0.19-0.40). MAFLD was associated with the COVID-19 disease severity OR 3.07 (95% CI: 2.30-4.09). Similarly, MAFLD was associated with an increased risk of ICU admission compared to the non-MAFLD group OR 1.46 (95% CI: 1.12-1.91). Lastly, the association between MAFLD and COVID-19 mortality was not statistically significant OR 1.45 (95% CI: 0.74-2.84).</p><p><strong>Conclusions: </strong>In this study, a high percentage of COVID-19 patients had MAFLD. Moreover, MAFLD patients had an increased risk of COVID-19 disease severity and ICU admission rate.</p>","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"241-246"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/5f/15-241.PMC9311786.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Takotsubo Cardiomyopathy in a Vaccinated Patient with Severe COVID-19.","authors":"Osman Rahimi,&nbsp;Neilmegh Varada,&nbsp;Chriselyn Palma,&nbsp;Omar Al Taweel,&nbsp;Kachon Lei,&nbsp;Dalia Hawwass,&nbsp;Chowdhury Ahsan","doi":"10.17161/kjm.vol15.16456","DOIUrl":"https://doi.org/10.17161/kjm.vol15.16456","url":null,"abstract":"Takotsubo Cardiomyopathy in a Vaccinated Patient with Severe COVID-19 Osman Rahimi, D.O., Neilmegh Varada, D.O., Chriselyn Palma, D.O., Omar Al Taweel, M.D., Kachon Lei, M.D., Dalia Hawwass, M.D., Chowdhury Ahsan, M.D., Ph.D. University of Nevada-Las Vegas, Kirk Kerkorian School of Medicine, Las Vegas, NV Received Feb. 7, 2022; Accepted for publication April 26, 2022; Published online July 21, 2022 https://doi.org/10.17161/kjm.vol15.16456","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"255-256"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/c4/15-255.PMC9311875.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mobile Health Clinics as a Healthcare Delivery Model to Address Community Disparities.","authors":"Som P Singh,&nbsp;Farhan Baig,&nbsp;Shipra Singh","doi":"10.17161/kjm.vol15.16543","DOIUrl":"https://doi.org/10.17161/kjm.vol15.16543","url":null,"abstract":"Mobile Health Clinics as a Healthcare Delivery Model to Address Community Disparities Som P. Singh1, Farhan Baig1, Shipra Singh, M.D.1,2 1University of Missouri-Kansas City, School of Medicine, Kansas City, MO 2Central Michigan University, College of Medicine, Saginaw, MI Received Feb. 20, 2022; Accepted for publication April 21, 2022; Published online July 21, 2022 https://doi.org/10.17161/kjm.vol15.16543","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"259-261"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/64/33/15-259.PMC9311629.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypertension and Cardiovascular Diseases among Electronic and Combustible Cigarette Users.","authors":"Grace E Falk,&nbsp;Hayrettin Okut,&nbsp;Mohinder R Vindhyal,&nbsp;Elizabeth Ablah","doi":"10.17161/kjm.vol15.16752","DOIUrl":"https://doi.org/10.17161/kjm.vol15.16752","url":null,"abstract":"<p><strong>Introduction: </strong>Combustible cigarette use is associated with an increased risk of several cardiovascular diseases; however, less is known about associations between these cardiovascular conditions and electronic cigarette use.</p><p><strong>Methods: </strong>This study investigated relationships between electronic and/or combustible cigarette use and diagnoses of cardiovascular diseases using the National Health Interview Survey from 2014, 2016, 2017, and 2018.</p><p><strong>Results: </strong>Compared to non-users, dual users of electronic and combustible cigarettes had increased likelihood of having prior diagnoses of hypertension (OR 1.660, 95% CI = 1.519-1.814), stroke (OR 2.396, 95% CI = 2.011-2.855), diabetes mellitus (OR 1.219, 95% CI = 1.108-1.341), coronary artery disease (OR 2.211, 95% CI = 1.837-2.660), and myocardial infarction (OR 3.839, 95% CI = 3.232-4.560). Exclusive use of electronic cigarettes was associated with an increased likelihood of having hypertension compared to non-users (OR 1.244, 95% CI = 1.048-1.477).</p><p><strong>Conclusions: </strong>There were no differences in diagnoses of stroke, diabetes mellitus, coronary artery disease, or myocardial infarction among exclusive electronic cigarette users compared to non-users; however, these associations could change as young electronic cigarette users with hypertension age, indicating the need for continued research.</p>","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"226-230"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/9a/15-226.PMC9311785.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Outcome of Different Postoperative Prophylactic Strategies on Symptomatic Venous Thromboembolism after Total Knee Arthroplasty.","authors":"Seth M Wardyn,&nbsp;Alexander C M Chong,&nbsp;Bruce E Piatt","doi":"10.17161/kjm.vol15.16367","DOIUrl":"https://doi.org/10.17161/kjm.vol15.16367","url":null,"abstract":"<p><strong>Introduction: </strong>The objective of this study was to evaluate the use of different post-operative prophylactic strategies on the rates of symptomatic venous thromboembolic events (VTE) incidence after primary total knee arthroplasty (TKA).</p><p><strong>Methods: </strong>A retrospective study of patients who underwent primary TKA procedure was performed from January 2015 through July 2020. Outcomes examined prophylaxis medication used during inpatient and outpatient care, amount of medication, length of medication, complications occurring within 90 days post-operatively, including symptomatic VTE (deep venous thrombosis (DVT), and pulmonary embolism (PE)), gastrointestinal (GI) bleeding requiring medical attention, change in management protocols after post-operative complications, and mortality.</p><p><strong>Results: </strong>In total, 5,663 cases were included (mean age 66 ± 10 years, mean BMI 34.1 ± 7.1kg/m²). The overall post-operative complication rate was 0.9% (DVT: 0.5%, PE: 0.3%, VTE: 0.04%, and GI bleeding: 0.09%). Enoxaparin use as inpatient anticoagulation medication was reduced significantly (67% vs. 13%, p < 0.001), and apixaban was increased significantly (6% vs. 49%, p < 0.001). Average hospital stays were reduced significantly among the years (3 ± 2 days vs. 2 ± 1 days, p < 0.001), and complication rates were not significantly different between the five years (~1%, p < 0.001). Most post-operative complications occurred on either aspirin 325 mg (36%) or apixaban (26%). However, the relative risk ratio results indicating that utilization of warfarin, rivaroxaban, and aspirin 81 mg as outpatient anticoagulation medication were more likely to increase the risk of symptomatic VTE incidence compared to other anticoagulants. The average time of complication detected was 21 ± 21 days (range: 1 - 87 days). More than 54% of complication events occurred after the patient had completed their medication (enoxaparin, rivaroxaban, and apixaban).</p><p><strong>Conclusions: </strong>The observed incidence of symptomatic VTE in this study was similar to previous studies regardless of the type of post-operative inpatient or outpatient prophylaxis prescribed. The ultimate choice of prophylaxis should remain with the treating physician and their knowledge of a particular patient's medical history.</p>","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"231-236"},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/e9/15-231.PMC9311630.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40638070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thiazide-Induced Pancreatitis.","authors":"Nourhan Chaaban,&nbsp;Shilpa Kshatriya","doi":"10.17161/kjm.vol15.16534","DOIUrl":"https://doi.org/10.17161/kjm.vol15.16534","url":null,"abstract":"INTRODUCTION Acute pancreatitis (AP) is an acute inflammatory disease of the pancreas and is associated with a wide spectrum of clinical manifestations, ranging from mild disease to more severe forms, even requiring intensive care unit hospitalization.1 The reported annual incidence of acute pancreatitis in the United States ranges from 4.9 to 35 per 100,000 population.2 Pancreatitis due to medications is rare (< 5%).3 Published reports have identified about 50 drugs that definitely or possibly may be held responsible for inducing acute pancreatitis.4 Also, the global prevalence of hypertension is high, and among nonpregnant adults in the United States, treatment of hypertension is the most common reason for office visits and the use of chronic prescription medications.5 Drug-induced pancreatitis remains a challenge for physicians. It needs further consideration when a patient has a clinical presentation suggestive of acute pancreatitis without a significant cause. This report involved a case of hydrochlorothiazide-induced pancreatitis in a patient who recently had started this medication for blood pressure control. We aimed to determine the association of thiazide drugs with the incidence of pancreatitis and add to the literature this rare case.","PeriodicalId":17991,"journal":{"name":"Kansas Journal of Medicine","volume":" ","pages":"220-221"},"PeriodicalIF":0.0,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/ee/15-220.PMC9225032.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40406343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}